Urinary Protein as a Marker for Systolic Blood Pressure Reduction in Patients with Type 2 Diabetes Mellitus Participating in an In-Hospital Diabetes Education Program

References

• . Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434–444
   PubMed Web of Science ®Google Scholar
• . Hansson L, Zanchetti A, Carruthers SG, . Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351(9118):1755–1762
   PubMed Web of Science ®Google Scholar
• . Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589
   PubMed Web of Science ®Google Scholar
• . Sigurdardottir AK, Jonsdottir H, Benediktsson R. Outcomes of educational interventions in type 2 diabetes: WEKA data-mining analysis. Patient Educ Couns. 2007;67(1–2):21–31
   PubMed Web of Science ®Google Scholar
• . Peterson KA, Hughes M. Readiness to change and clinical success in a diabetes educational program. J Am Board Fam Pract. 2002;15(4):266–271
   PubMedGoogle Scholar
• . Kawahara T, Takahashi K, Inazu T, . Reduced progression to type 2 diabetes from impaired glucose tolerance after a 2-day in-hospital diabetes educational program: the Joetsu Diabetes Prevention Trial. Diabetes Care. 2008;31(10):1949–1954
   PubMed Web of Science ®Google Scholar
• . Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42(5):878–884
   PubMed Web of Science ®Google Scholar
• . Zoungas S, de Galan BE, Ninomiya T, ; ADVANCE Collaborative Group. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care. 2009;32(11):2068–2074
   PubMed Web of Science ®Google Scholar
• . Ogihara T, Nakao K, Fukui T, ; Candesartan Antihypertensive Survival Evaluation in Japan Trial Group. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension. 2008;51(2):393–398
   PubMed Web of Science ®Google Scholar
• . Ruilope LM, Salvetti A, Jamerson K, . Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol. 2001;12(2):218–225
   PubMed Web of Science ®Google Scholar
• . Matsuo S, Imai E, Horio M, ; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–992
   PubMed Web of Science ®Google Scholar
• . Ogihara T, Kikuchi K, Matsuoka H, ; Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32(1):3–107
   PubMed Web of Science ®Google Scholar
• . Chobanian AV, Bakris GL, Black HR, ; National Heart, Lung, and Blood Institute Joint Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572
   PubMed Web of Science ®Google Scholar
• . Hirano T, Sakaue T, Misaki A, . Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII. Kidney Int. 2003;63(6):2171–2177
   PubMed Web of Science ®Google Scholar
• . Gerstein HC, Mann JF, Yi Q, ; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421–426
   PubMed Web of Science ®Google Scholar
• . Irie F, Iso H, Sairenchi T, . The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006;69(7):1264–1271
   PubMed Web of Science ®Google Scholar
• . Lin M, Chen Y, Sigal RJ. Impacts of diabetes and hypertension on the risk of hospitalization among less educated people. J Hum Hypertens. 2007;21(3):225–230
   PubMed Web of Science ®Google Scholar
• . Funnell MM, Donnelly MB, Anderson RM, Johnson PD, Oh MS. Perceived effectiveness, cost, and availability of patient education methods and materials. Diabetes Educ. 1992;18(2):139–145
   PubMedGoogle Scholar
• . Japan Diabetes Society. Exercise therapy. In: Japan Diabetes Society, ed. Treatment Guide for Diabetes 2010. Tokyo, Japan: Bunkodo Co., Ltd.; 2010:42–44
   Google Scholar
• . Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913
   PubMed Web of Science ®Google Scholar
• . Tashiro E, Miura S, Koga M, . Crossover comparison between the depressor effects of low and high work-rate exercise in mild hypertension. Clin Exp Pharmacol Physiol. 1993;20(11):689–696
   PubMed Web of Science ®Google Scholar
• . Bakris GL, Williams M, Dworkin L, ; Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36(3):646–661
   PubMed Web of Science ®Google Scholar
• . Neumann J, Ligtenberg G, Klein IH, . Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension. 2007;49(3):506–510
   PubMed Web of Science ®Google Scholar
• . Matsukawa T, Gotoh E, Minamisawa K, . Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol. 1991;261(3 pt 2):R690–R696
   PubMedGoogle Scholar
• . Ligtenberg G, Blankestijn PJ, Oey PL, . Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med. 1999;340(17):1321–1328
   PubMed Web of Science ®Google Scholar
• . Kobori H, Ozawa Y, Suzaki Y, . Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens. 2006;19(5):541–550
   PubMed Web of Science ®Google Scholar
• . Arakawa K. Antihypertensive mechanism of exercise. J Hypertens. 1993;11(3):223–229
   PubMed Web of Science ®Google Scholar
• . Straznicky NE, Lambert EA, Nestel PJ, . Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes. 2010;59(1):71–79
   PubMed Web of Science ®Google Scholar
• . Kushiro T, Kobayashi F, Osada H, . Role of sympathetic activity in blood pressure reduction with low calorie regimen. Hypertension. 1991;17(6 pt 2):965–968
   PubMed Web of Science ®Google Scholar
• . Cheng LT, Gao YL, Gu Y, . Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease. Nephrol Dial Transplant. 2008;23(12):3895–3900
   PubMed Web of Science ®Google Scholar
• . Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 2005;45(3):494–501
   PubMed Web of Science ®Google Scholar
• . Ohya Y, Iseki K, Iseki C, Miyagi T, Kinjo K, Takishita S. Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis. 2006;47(5):790–797
   PubMed Web of Science ®Google Scholar
• . Berry KL, Cameron JD, Dart AM, . Large-artery stiffness contributes to the greater prevalence of systolic hypertension in elderly women. J Am Geriatr Soc. 2004;52(3):368–373
   PubMed Web of Science ®Google Scholar
• . Izzo JL Jr. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol. 2004;19(4):341–352
   PubMed Web of Science ®Google Scholar
• . Song JH, Cha SH, Lee HJ, . Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease. Nephrol Dial Transplant. 2006;21(3):683–689
   PubMed Web of Science ®Google Scholar
• . Rubio-Guerra AF, Arceo-Navarro A, Vargas-Ayala G, Rodriquez-Lopez L, Lozano-Nuevo JJ, Gomez-Harper CT. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes. Diabetes Care. 2004;27(7):1688–1691
   PubMed Web of Science ®Google Scholar